Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $376M (99.2% shares, 0.8% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HROW | HARROW HEALTH INC | 3,820,000 | $42.78M | 11.4% | $6.06 | +95.2% | COM | 415858109 |
| TGTX | TG THERAPEUTICS INC | 2,215,000 | $37.83M | 10.1% | $13.60 | -14.6% | COM | 88322Q108 |
| — | ACELYRIN INC | 4,146,138 | $30.93M | 8.2% | $20.90 | — | COM | 00445A100 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 610,000 | $28.04M | 7.5% | $12.73 | +147.8% | COM | 76243J105 |
| OCUL | OCULAR THERAPEUTIX INC | 6,070,000 | $27.07M | 7.2% | $4.90 | -39.7% | COM | 67576A100 |
| CPRX | CATALYST PHARMACEUTICALS INC | 1,257,200 | $21.44M | 5.7% | $13.39 | +2.1% | COM | 14888U101 |
| KROS | KEROS THERAPEUTICS INC | 357,500 | $14.21M | 3.8% | $47.35 | -33.8% | COM | 492327101 |
| IDYA | IDEAYA BIOSCIENCES INC | 311,500 | $11.08M | 2.9% | $17.38 | +71.8% | COM | 45166A102 |
| ETON | ETON PHARMACEUTICALS INC | 2,529,887 | $11.08M | 2.9% | $5.82 | -31.1% | COM | 29772L108 |
| CRNX | CRINETICS PHARMACEUTICALS INC | 307,500 | $10.94M | 2.9% | $20.62 | +48.7% | COM | 22663K107 |
| ARVN | ARVINAS INC | 263,700 | $10.85M | 2.9% | $23.38 | 0.0% | COM | 04335A105 |
| CDXS | CODEXIS INC | 3,045,525 | $9.289M | 2.5% | $2.50 | -14.2% | COM | 192005106 |
| BHVN | BIOHAVEN LTD | 200,000 | $8.56M | 2.3% | $14.12 | +120.2% | COM | G1110E107 |
| EWTX | EDGEWISE THERAPEUTICS INC | 699,000 | $7.647M | 2.0% | $10.13 | -30.7% | COM | 28036F105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 897,000 | $7.293M | 1.9% | $6.29 | -16.8% | COM | 462260100 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 1,960,000 | $6.331M | 1.7% | $2.72 | 0.0% | COM | 03969K108 |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | 308,500 | $6.25M | 1.7% | $19.77 | -33.5% | COM | 35104E100 |
| — | MARINUS PHARMACEUTICALS INC | 563,500 | $6.125M | 1.6% | $3.98 | — | COM NEW | 56854Q200 |
| PCVX | VAXCYTE INC | 90,000 | $5.652M | 1.5% | $38.73 | +34.1% | COM | 92243G108 |
| LQDA | LIQUIDIA CORPORATION | 445,000 | $5.353M | 1.4% | $5.52 | +30.4% | COM NEW | 53635D202 |
| TARA | PROTARA THERAPEUTICS INC | 2,692,594 | $5.049M | 1.3% | $29.10 | -94.9% | COM STK | 74365U107 |
| URGN | UROGEN PHARMA LTD | 320,000 | $4.8M | 1.3% | $8.22 | +58.0% | COM | M96088105 |
| XOMA | XOMA CORP DEL | 250,000 | $4.625M | 1.2% | $11.26 | +46.2% | COM NEW | 98419J206 |
| — | APPLIED THERAPEUTICS | 1,092,500 | $3.66M | 1.0% | $2.65 | — | COM | 03828A101 |
| RLMD | RELMADA THERAPEUTICS INC | 877,000 | $3.631M | 1.0% | $2.96 | -0.0% | COM | 75955J402 |
| — | BIODESIX | 496,500 | $3.611M | 1.0% | $6.72 | — | COM | 09075X108 |
| TRVI | TREVI THERAPEUTICS INC | 2,535,000 | $3.397M | 0.9% | $2.05 | -26.1% | COM | 89532M101 |
| — | JASPER THERAPEUTICS INC | 3,985,340 | $3.144M | 0.8% | $0.79 | — | COM | 471871103 |
| NTLA | INTELLIA THERAPEUTICS INC | 99,000 | $3.019M | 0.8% | $28.74 | 0.0% | COM | 45826J105 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 265,388 | $2.964M | 0.8% | $9.16 | 0.0% | ORDINARY SHARES | N62509109 |
| — | GOSSAMER BIO INC | 8,000,000 | $2.915M | 0.8% | $0.39 | — | NOTE 5.000% 6/0 | 38341PAA0 |
| LRMR | LARIMAR THERAPEUTICS INC | 623,500 | $2.837M | 0.8% | $7.31 | -53.9% | COM | 517125100 |
| VTYX | VENTYX BIOSCIENCES INC | 1,140,000 | $2.816M | 0.7% | $9.50 | 0.0% | COM | 92332V107 |
| SYRS | SYROS PHARMACEUTICALS INC | 359,370 | $2.799M | 0.7% | $3.43 | 0.0% | COM NEW | 87184Q206 |
| GOSS | GOSSAMER BIO INC | 2,982,200 | $2.721M | 0.7% | $1.22 | -39.4% | COM | 38341P102 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 112,700 | $2.584M | 0.7% | $17.50 | 0.0% | COM | 74366E102 |
| KALV | KALVISTA PHARMACEUTICALS INC | 150,000 | $1.837M | 0.5% | $5.36 | +69.8% | COM | 483497103 |
| VSTM | VERASTEM INC | 211,400 | $1.721M | 0.5% | $8.32 | -13.7% | COM NEW | 92337C203 |
| NYXH | NYXOAH S A | 344,800 | $1.6M | 0.4% | $7.81 | -29.5% | SHS | B6S7WD106 |
| — | MORPHOSYS AG | 145,000 | $1.435M | 0.4% | $3.87 | — | SPONSORED ADS | 617760202 |
| PGEN | PRECIGEN INC | 1,012,500 | $1.357M | 0.4% | $1.40 | -15.9% | COM | 74017N105 |
| — | SUTRO BIOPHARMA INC | 301,491 | $1.293M | 0.3% | $4.29 | — | COM | 869367102 |
| CNTX | CONTEXT THERAPEUTICS INC | 975,000 | $1.102M | 0.3% | $1.07 | 0.0% | COM | 21077P108 |
| FULC | FULCRUM THERAPEUTICS INC | 130,000 | $878K | 0.2% | $4.44 | 0.0% | COM | 359616109 |
| — | ALIGOS THERAPEUTICS INC | 1,297,000 | $861K | 0.2% | $0.66 | — | COM | 01626L105 |
| — | KINIKSA PHARMACEUTICALS LTD | 37,500 | $640K | 0.2% | $17.07 | — | COM CLASS A | G5269C101 |